Increased Circulatory Extrarenal 1?,25-Dihydroxyvitamin D3 in Bilaterally Nephrectomized Rats

dc.contributor.authorDabak, Murat
dc.contributor.authorDabak, Durrin O.
dc.contributor.authorKuloglu, Tuncay
dc.contributor.authorBaydar, Ersoy
dc.contributor.authorBulut, Hakan
dc.contributor.authorOzoner, Ozgur
dc.date.accessioned2026-08-12T17:18:38Z
dc.date.issued2020
dc.departmentFırat Üniversitesi
dc.description.abstractBackground: Extrarenal 1 alpha,25-dihydroxyvitamin D-3 (1,25-D) locally produced by immune cells plays crucial roles in the regulation of the immune system. However, in vivo status of extrarenal 1,25-D and 25-hydroxyvitamin D (25-D) in acute inflammatory conditions are unknown. Objective: The aim of this study was to determine the extrarenal 1,25-D level in circulation in bilaterally nephrectomized rats, induced by low-dose lipopolysaccharide (LPS). Methods: Renal 1,25-D synthesis was terminated through bilateral nephrectomy in rats. The rats received intraperitoneal LPS (50 mu g/kg BW) three times and the experiment was ended 24 hours after nephrectomy. Serum 1,25-D, 25-D, calcium, phosphorus, intact parathyroid hormone, and calcitonin levels were measured and immunohistochemistry was applied to detect the sources of extrarenal 1,25-D synthesis. Results: Circulatory 1,25-D concentration remarkably increased in both LPS-treated and non-treated bilaterally nephrectomized rats. Elevated circulatory 1,25-D did not have hypercalcemic endocrinal effects. The increased 1,25-D level also resulted in a concurrent rapid and dramatic depletion of circulatory 25-D. Conclusion: Extrarenal 1,25-D could enter into the systemic circulation and, therefore, might have systemic effects besides its autocrine and paracrine functions.
dc.description.sponsorshipScientific and Technological Research Council of Turkey (TUBITAK) [2140681]
dc.description.sponsorshipThis work was supported by the Scientific and Technological Research Council of Turkey (TUBITAK) (Project Number: 2140681).
dc.identifier.doi10.2174/1871530320666200530222426
dc.identifier.endpage1530
dc.identifier.issn1871-5303
dc.identifier.issn2212-3873
dc.identifier.issue9
dc.identifier.orcid0000-0001-9874-3838
dc.identifier.orcid0000-0001-7354-0655
dc.identifier.orcid0000-0002-5184-6087
dc.identifier.pmid32473004
dc.identifier.scopus2-s2.0-85092184002
dc.identifier.scopusqualityQ2
dc.identifier.startpage1523
dc.identifier.urihttps://doi.org/10.2174/1871530320666200530222426
dc.identifier.urihttps://hdl.handle.net/11508/53120
dc.identifier.volume20
dc.identifier.wosWOS:000587329600017
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherBentham Science Publ Ltd
dc.relation.ispartofEndocrine Metabolic & Immune Disorders-Drug Targets
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subject1 alpha,25-dihydroxyvitamin D-3
dc.subject25-hydroxyvitamin D
dc.subjectinflammation
dc.subjectextrarenal
dc.subjectanephric
dc.subjectrat
dc.titleIncreased Circulatory Extrarenal 1?,25-Dihydroxyvitamin D3 in Bilaterally Nephrectomized Rats
dc.typeArticle

Dosyalar